eXIthera Pharmaceuticals' Series B Round

eXIthera Pharmaceuticals raised a round of funding on August 25, 2017. Investors include Schooner Capital.

eXIthera Pharmaceuticals is a an early stage biotech company focused on developing small molecule pharmaceuticals to inhibit Factor Xla, an important enzyme in the blood coagulation pathway.…

Articles about eXIthera Pharmaceuticals' Series B Round: